litlas
ログインアカウント作成

Paul Angulo

1998–2016 年に発表

84
論文数
36,118
被引用数
83
h 指数
84
i10 指数

被引用数

Paul Angulo の年別被引用数1991 年: 被引用 1 件1996 年: 被引用 1 件1998 年: 被引用 1 件1999 年: 被引用 4 件2000 年: 被引用 21 件2001 年: 被引用 38 件2002 年: 被引用 101 件2003 年: 被引用 143 件2004 年: 被引用 224 件2005 年: 被引用 260 件2006 年: 被引用 317 件2007 年: 被引用 357 件2008 年: 被引用 504 件2009 年: 被引用 484 件2010 年: 被引用 496 件2011 年: 被引用 456 件2012 年: 被引用 427 件2013 年: 被引用 517 件2014 年: 被引用 463 件2015 年: 被引用 528 件2016 年: 被引用 480 件2017 年: 被引用 477 件2018 年: 被引用 378 件2019 年: 被引用 1,188 件2020 年: 被引用 1,194 件2021 年: 被引用 1,085 件2022 年: 被引用 821 件2023 年: 被引用 543 件2024 年: 被引用 715 件2025 年: 被引用 287 件2026 年: 被引用 10 件1992〜1995 年は被引用が無いため表示していません1997 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,201 件、この内訳の 24%中国: 引用元論文 1,202 件、この内訳の 9%イタリア: 引用元論文 944 件、この内訳の 7.1%イギリス: 引用元論文 821 件、この内訳の 6.1%日本: 引用元論文 636 件、この内訳の 4.8%ドイツ: 引用元論文 540 件、この内訳の 4%韓国: 引用元論文 486 件、この内訳の 3.6%フランス: 引用元論文 424 件、この内訳の 3.2%スペイン: 引用元論文 393 件、この内訳の 2.9%カナダ: 引用元論文 373 件、この内訳の 2.8%オーストラリア: 引用元論文 352 件、この内訳の 2.6%オランダ: 引用元論文 249 件、この内訳の 1.9%
0%24%その他 28%

機関

分野

  • Medicine89.6%
  • Biochemistry, Genetics and Molecular Biology6.4%
  • Nursing0.7%
  • Immunology and Microbiology0.7%
  • Neuroscience0.6%
  • Pharmacology, Toxicology and Pharmaceutics0.5%
  • その他1.5%

トピック

  • Liver Disease Diagnosis and Treatment26.3%
  • Liver Disease and Transplantation7.7%
  • Diet, Metabolism, and Disease6.2%
  • Liver Diseases and Immunity5%
  • Diabetes, Cardiovascular Risks, and Lipoproteins4%
  • Alcohol Consumption and Health Effects3.5%
  • その他47.3%

共著者

全論文

検索で開く
  1. Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

    著者: Paul Angulo, David E. Kleiner, Sanne Dam‐Larsen, Leon A. Adams, Einar S. Björnsson, Phunchai Charatcharoenwitthaya, Peter R. Mills, Jill C. Keach, Heather Lafferty, Alisha C. Stahler, Svanhildur Hafliðadóttir, Flemming Bendtsen - Gastroenterology 2015 被引用: 2,950

  2. The NAFLD fibrosis score

    著者: Paul Angulo, Jason M. Hui, Giulio Marchesini, Ellisabetta Bugianesi, Jacob George, Geoffrey C. Farrell, Felicity Enders, Sushma Saksena, Alastair D. Burt, John P. Bida, Keith D. Lindor, Schuyler O. Sanderson, Marco Lenzi, Leon A. Adams, James G. Kench, Terry M. Therneau, Christopher P. Day - Hepatology 2007 被引用: 3,200

  3. Nonalcoholic Fatty Liver Disease

    著者: Paul Angulo - New England Journal of Medicine 2002 被引用: 5,199

  4. The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study

    著者: Leon A. Adams, James Lymp, Jenny St. Sauver, Schuyler O. Sanderson, Keith D. Lindor, Ariel E. Feldstein, Paul Angulo - Gastroenterology 2005 被引用: 2,896

  5. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis

    著者: Ariel E. Feldstein, Ali Canbay, Paul Angulo, Makiko Taniai, Lawrence J. Burgart, Keith D. Lindor, Gregory J. Gores - Gastroenterology 2003 被引用: 1,078

  6. Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis

    著者: Aldo J. Montaño‐Loza, Paul Angulo, Judith Meza–Junco, Carla M. Prado, Michael B. Sawyer, Crystal Beaumont, Nina Esfandiari, Mang Ma, Vickie E. Baracos - Journal of Cachexia Sarcopenia and Muscle 2015 被引用: 505

  7. Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

    著者: Paul Angulo, Elisabetta Bugianesi, Einar S. Björnsson, Phunchai Charatcharoenwitthaya, Peter R. Mills, Francisco Barrera, Svanhildur Hafliðadóttir, Christopher P. Day, Jacob George - Gastroenterology 2013 被引用: 507

  8. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years

    著者: Ariel E. Feldstein, Phunchai Charatcharoenwitthaya, Sombat Treeprasertsuk, Joanne T. Benson, Felicity Enders, Paul Angulo - Gut 2009 被引用: 729

  9. Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1

    著者: Thomas Boyer, Arun J. Sanyal, Florence Wong, R. Todd Frederick, John R. Lake, Jacqueline G. O’Leary, Daniel Ganger, Khurram Jamil, S. Chris Pappas, Samuel H. Sigal, Santiago J. Muñoz, Vishal Patel, Paul Y. Kwo, Jasmohan S. Bajaj, Tarek Hassanein, Kirti Shetty, Rohit Satoskar, K. Rajender Reddy, Marlyn J. Mayo, Víctor Araya, Nikroo Hashemi, Eyob Feyssa, Lorenzo Rossaro, David Kravetz, Priya Grewal, Ram Subramanian, Kevin Korenblat, Yuri Genyk, Fredric Regenstein, Joseph F. Buell, Nathan J. Shores, Sukru Emre, Andrea Duchini, Atif Zaman, Marco Olivera‐Martinez, Michael K. Porayko, Alex S. Befeler, K. Gautham Reddy, Maria Hernandez, Stephen D. Zucker, Hugo E. Vargas, Michael P. Curry, Adnan Said, Kris V. Kowdley, Terry Box, David S. Barnes, Marie Noëlle Pépin, Madhavi Rudraraju, Paul Angulo, Howard Monsour, David S. Wolf, Charles D. Howell, Fredric Regenstein, Antonio Sánchez, Hany Elbeshbeshy, Michael B. Fallon, Colin Swales, David A. Sass, Eva U. Sotil, Brendan M. McGuire, Richard Gilroy, Juan A. Guerrero, Mark Wong, Obaid S. Shaikh, S. Tobia Gonzalez, Zeid Kayali - Gastroenterology 2016 被引用: 305

  10. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies

    著者: Leon A. Adams, Schuyler O. Sanderson, Keith D. Lindor, Paul Angulo - Journal of Hepatology 2004 被引用: 912

  11. Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome

    著者: Amedeo Lonardo, Stefano Ballestri, Giulio Marchesini, Paul Angulo, Paola Loria - Digestive and Liver Disease 2014 被引用: 698

  12. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial

    著者: Keith D. Lindor, Kris V. Kowdley, Jenny Heathcote, Edwyn M Harrison, Roberta A. Jorgensen, Paul Angulo, James Lymp, Lawrence J. Burgart, Patrick Colin - Hepatology 2004 被引用: 729

  13. Fibrosis in Nonalcoholic Fatty Liver Disease: Mechanisms and Clinical Implications

    著者: Paul Angulo, Mariana Verdelho Machado, Anna Mae Diehl - Seminars in Liver Disease 2015 被引用: 137

  14. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease

    著者: Valério Nobili, Melania Manco, Rita De Vito, Vincenzo Di Ciommo, Donatella Comparcola, Maria Rita Sartorelli, Fiorella Piemonte, Matilde Marcellini, Paul Angulo - Hepatology 2008 被引用: 409

  15. The Value of Serum CA 19-9 in Predicting Cholangiocarcinomas in Patients with Primary Sclerosing Cholangitis

    著者: Cynthia Levy, James Lymp, Paul Angulo, Gregory J. Gores, Nicholas F. LaRusso, Keith D. Lindor - Digestive Diseases and Sciences 2005 被引用: 339

  16. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study

    著者: Neeraj Bhala, Paul Angulo, David van der Poorten, Eric Lee, Jason M. Hui, Giorgio Maria Saracco, Leon A. Adams, Phunchai Charatcharoenwitthaya, Joanne Topping, Elisabetta Bugianesi, Christopher P. Day, Jacob George - Hepatology 2011 被引用: 451

  17. The Natural History of Small-Duct Primary Sclerosing Cholangitis

    著者: Einar S. Björnsson, Rolf Olsson, Annika Bergquist, Stefan Lindgren, Barbara Braden, Roger W. Chapman, Kirsten Muri Boberg, Paul Angulo - Gastroenterology 2008 被引用: 305

  18. Utility of a New Model to Diagnose an Alcohol Basis for Steatohepatitis

    著者: Winston Dunn, Paul Angulo, Schuyler O. Sanderson, Laith H. Jamil, Linda Stadheim, Charles B. Rosen, Michael Malinchoc, Patrick S. Kamath, Vijay H. Shah - Gastroenterology 2006 被引用: 141

  19. Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study

    著者: Winston Dunn, Ronghui Xu, Deborah L. Wingard, Christopher S. Rogers, Paul Angulo, Zobair M. Younossi, Jeffrey B. Schwimmer - The American Journal of Gastroenterology 2008 被引用: 321

  20. Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction

    著者: Leon A. Adams, Ariel E. Feldstein, Keith D. Lindor, Paul Angulo - Hepatology 2004 被引用: 252

  21. NAFLD in children: A prospective clinical-pathological study and effect of lifestyle advice

    著者: Valério Nobili, Matilde Marcellini, Rita De Vito, Paolo Ciampalini, Fiorella Piemonte, Donatella Comparcola, Maria Rita Sartorelli, Paul Angulo - Hepatology 2006 被引用: 351

  22. Noninvasive evaluation of NAFLD

    著者: Laurent Castéra, Valérie Vilgrain, Paul Angulo - Nature Reviews Gastroenterology & Hepatology 2013 被引用: 272

  23. Prevalence and Indicators of Portal Hypertension in Patients With Nonalcoholic Fatty Liver Disease

    著者: Flavia Mendes, Ayako Suzuki, Schuyler O. Sanderson, Keith D. Lindor, Paul Angulo - Clinical Gastroenterology and Hepatology 2012 被引用: 108

  24. The Evaluation of Hepatic Fibrosis Scores in Children with Nonalcoholic Fatty Liver Disease

    著者: Sana Mansoor, Lisa Yerian, Rohit Kohli, Stavra A. Xanthakos, Paul Angulo, Simon C. Ling, Rocío López, Christine Carter‐Kent, Ariel E. Feldstein, Naim Alkhouri - Digestive Diseases and Sciences 2014 被引用: 100